Lutris Pharma appoints Mori Arkin to its Board of Directors
– ISRAEL, Tel Aviv – Lutris Pharma, a clinical-stage biopharmaceutical company focused on improving anti-cancer therapies by reducing dose-limiting side effects, announced the appointment of Mori Arkin to its Board of Directors.…